CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis

Nature Immunology

Volumn 17, Issue 8, 2016, Pages 985-996

  Cibrian, Danay ^a   Saiz, María Laura ^a   De La Fuente, Hortensia ^a   Sánchez Díaz, Raquel ^b   Moreno Gonzalo, Olga ^a   Jorge, Inmaculada ^b   Ferrarini, Alessia ^b   Vázquez, Jesús ^b   Punzón, Carmen ^a   Fresno, Manuel ^a   Vicente Manzanares, Miguel ^a   Daudén, Esteban ^c   Fernández Salguero, Pedro M ^d   Martín, Pilar ^b   Sánchez Madrid, Francisco ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CD69 ANTIGEN; CD98 ANTIGEN; INTERLEUKIN 22; INTERLEUKIN 23; STAT3 PROTEIN; TRYPTOPHAN; AMINO ACID TRANSPORTER; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; LECTIN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; SLC7A7 PROTEIN, MOUSE; T LYMPHOCYTE ANTIGEN;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATITIS; GAMMA DELTA T LYMPHOCYTE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; ENDOCYTOSIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; SKIN; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; ANTIGENS, CD; ANTIGENS, CD98; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; ENDOCYTOSIS; INTERLEUKIN-23; INTERLEUKINS; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, ARYL HYDROCARBON; SKIN; T-LYMPHOCYTE SUBSETS; TH17 CELLS; TRYPTOPHAN;

EID: 84976908671     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3504     Document Type: Article

References (49)

1. Di Meglio P., Villanova F., & Nestle F.O. Psoriasis. Cold Spring Harb. Perspect. Med. 4, a015354 (2014).
2. Lowes M.A., Suárez-Fariñas M., & Krueger J.G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227-255 (2014).
3. Leonardi C., et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366, 1190-1199 (2012).
4. Chan J.R., et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587 (2006).
5. Zheng Y., et al. Interleukin-22, A TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
6. Wolk K., et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not. J. Mol. Med. 87, 523-536 (2009).
7. Van Belle A.B., et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J. Immunol. 188, 462-469 (2012).
8. Prans E., et al. Copy number variations in IL22 gene are associated with psoriasis vulgaris. Hum. Immunol. 74, 792-795 (2013).
9. Shimauchi T., et al. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis. J. Dermatol. 40, 805-812 (2013).
10. Wolk K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasis. Eur. J. Immunol. 36, 1309-1323 (2006).
11. Martin B., Hirota K., Cua D.J., Stockinger B., & Veldhoen M. Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321-330 (2009).
12. Qiu J., et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92-104 (2012).
13. Veldhoen M., Hirota K., Christensen J., O?Garra A., & Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206, 43-49 (2009).
14. Smirnova A., et al. Evidence for new light-independent pathways for generation of the endogenous aryl hydrocarbon receptor agonist FICZ. Chem. Res. Toxicol. 29, 75-86 (2016).
15. Sinclair L.V., et al. Control of amino-Acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500-508 (2013).
16. Cai Y., et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 35, 596-610 (2011).
17. Laggner U., et al. Identification of A novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with A potential role in psoriasis. J. Immunol. 187, 2783-2793 (2011).
18. Pantelyushin S., et al. Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122, 2252-2256 (2012).
19. Ahlfors H., et al. IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J. Immunol. 193, 4602-4613 (2014).
20. Sumaria N., et al. Cutaneous immunosurveillance by self-renewing dermal γδ T cells. J. Exp. Med. 208, 505-518 (2011).
21. González-Amaro R., Cortés J.R., Sánchez-Madrid F., & Martín P. Is CD69 an effective brake to control inflammatory diseases?. Trends Mol. Med. 19, 625-632 (2013).
22. Sancho D., et al. CD69 downregulates autoimmune reactivity through active transforming growth factor-β production in collagen-induced arthritis. J. Clin. Invest. 112, 872-882 (2003).
23. Martín P., et al. The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. J. Allergy Clin. Immunol. 126, 355-365, 365.e1-365.e3 (2010).
24. Cruz-Adalia A., et al. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Circulation 122, 1396-1404 (2010).
25. Radulovic K., et al. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. J. Immunol. 188, 2001-2013 (2012).
26. Rutz S., Eidenschenk C., & Ouyang W. IL-22, not simply A Th17 cytokine. Immunol. Rev. 252, 116-132 (2013).
27. Martín P., et al. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol. Cell. Biol. 30, 4877-4889 (2010).
28. Mackay L.K., et al. The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294-1301 (2013).
29. Awasthi A., et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182, 5904-5908 (2009).
30. Shiow L.R., et al. CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540-544 (2006).
31. Ribot J.C., et al. CD27 is A thymic determinant of the balance between interferon-γ-And interleukin 17-producing gammadelta T cell subsets. Nat. Immunol. 10, 427-436 (2009).
32. Kashiwagi H., Yamazaki K., Takekuma Y., Ganapathy V., & Sugawara M. Regulatory mechanisms of SNAT2, an amino acid transporter, in L6 rat skeletal muscle cells by insulin, osmotic shock and amino acid deprivation. Amino Acids 36, 219-230 (2009).
33. Taylor P.M. Role of amino acid transporters in amino acid sensing. Am. J. Clin. Nutr. 99, S223-S230 (2014).
34. Harden J.L., et al. The tryptophan metabolism enzyme L-kynureninase is A novel inflammatory factor in psoriasis and other inflammatory diseases. J. Allergy Clin. Immunol. 137, 1830-1840 (2016).
35. Rizzo H.L., et al. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J. Immunol. 186, 1495-1502 (2011).
36. Boniface K., et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174, 3695-3702 (2005).
37. Mitra A., Raychaudhuri S.K., & Raychaudhuri S.P. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade. Cytokine 60, 38-42 (2012).
38. Finlay D.K., et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441-2453 (2012).
39. Mascanfroni I.D., et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. Nat. Med. 21, 638-646 (2015).
40. Fenczik C.A., et al. Distinct domains of CD98hc regulate integrins and amino acid transport. J. Biol. Chem. 276, 8746-8752 (2001).
41. Lauzurica P., et al. Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood 95, 2312-2320 (2000).
42. Di Meglio P., et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity 40, 989-1001 (2014).
43. Walter A., et al. Aldara activates TLR7-independent immune defence. Nat. Commun. 4, 1560 (2013).
44. van den Bogaard E.H., et al. Genetic and pharmacological analysis identifies A physiological role for the AHR in epidermal differentiation. J. Invest. Dermatol. 135, 1320-1328 (2015).
45. Furue M., et al. Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor. J. Dermatol. Sci. 80, 83-88 (2015).
46. Serre K., & Silva-Santos B. Molecular mechanisms of differentiation of murine pro-inflammatory γδ T cell subsets. Front. Immunol. 4, 431 (2013).
47. Shibata K., et al. Notch-Hes1 pathway is required for the development of IL-17-producing γδ T cells. Blood 118, 586-593 (2011).
48. Mukai M., & Tischkau S.A. Effects of tryptophan photoproducts in the circadian timing system: searching for A physiological role for aryl hydrocarbon receptor. Toxicol. Sci. 95, 172-181 (2007).
49. Kondo M., et al. Expansion of human peripheral blood gammadelta T cells using zoledronate. JoVE 55, 3152 (2011).